IL10 and melanoma: Here we evaluated whether IgG4, previously reported to be overexpressed in melanoma and other cancers with poor outcomes, can stimulate M2a and M2b macrophages to adapt immunosuppressive states and to enhance production of IL-10 and other immunomodulatory mediators.